Required and nonessential functions of nuclear factor-kappa B in bone cells

Bone

Volumn 25, Issue 1, 1999, Pages 137-139

  Boyce, B F ^a   Xing, L ^a   Franzoso, G ^b   Siebenlist, U ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; Lymphocytes; NF B; Osteoclasts; Osteopetrosis

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; POLYPEPTIDE; PROTEASOME; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UBIQUITIN;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; APOPTOSIS; B LYMPHOCYTE; BONE CELL; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; OSTEOCLAST; SHORT SURVEY; STRESS;

EID: 0032991354     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00105-2     Document Type: Article

References (34)

1. Anderson D.M., Maraskovsky E., Billingsley, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
2. Baldwin A.S. Jr. The NF-κB and IkB proteins new discoveries and insights . Annu Rev Immunol. 14:1996;649-683.
3. Barnes P.J., Karin M. Nuclear factor-kB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1997;1066-1071.
4. Beg A., Sha W., Bronson R., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
5. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
6. Bushdid P.B., Brantley D.M., Yull F.E., et al. Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature. 392:1998;615-618.
7. Franzoso G., Carlson L., Xing L., et al. Requirement for NF-κB in osteoclast and B cell development. Genes Dev. 11:1997;3482-3496.
8. Fuller K., Wong B., Fox S., Choi Y., Chambers T. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med. 188:1998;997-1001.
9. Galien R., Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res. 25:1997;2424-2429.
10. Grigoriadis A.E., Wang Z.-Q., Cecchini M.G., et al. c-Fos A key regulator of osteoclast-macrophage lineage determination and bone remodeling . Science. 266:1994;443-448.
11. Horowitz M.C. Cytokines and estrogen in bone; anti-osteoporotic effects. Science. 260:1993;626-627.
12. Iotsova V., Caamano J., Loy J., Lewin A., Bravo R. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nature Med. 3:1997;1285-1289.
13. Isomaki P., Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 29:1997;499-507.
14. Jilka R.L. Cytokine, bone remodeling, and estrogen deficiency. J Bone Min Res. 23:1998;75-81.
15. Jimi E., Nakamura I., Ikebe T., Akiyama S., Takahashi N., Suda T. Activation of NF-κB is involved in the survival of osteoclasts promoted by Interleukin-1. J Biol Chem. 273:1998;8799-8805.
16. Kanegae Y., Tavares A.T., Izpisua-Belmonte J.C., Verma I.M. Role of rel/NFκB transcription factors during the outgrowth of the vertebrate limb. Nature. 392:1998;611-614.
17. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
18. Lowe C., Yoneda T., Boyce B.F., Chen H., Mundy G.R., Soriano P. Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA. 90:1993;4485-4489.
19. May M.J., Ghosh S. Signal transduction through NF-κB. Immunology Today. 19:1998;80-88.
20. Ozaki K., Takeda H., Iwahashi H., Kitano S., Hanazawa S. NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. Fed Euro Biochem Soc. 410:1997;297-300.
21. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis - the second decade. Endocrinology. 139:1998;2659-2661.
22. Panganiban G., Irvine S., Lowe C., et al. The origin and evolution of animal appendages. Proc Natl Acad Sci USA. 94:1997;5162-5166.
23. Popoff S.N., Schneider G.B. Animal models of osteopetrosis the impact of recent molecular developments on novel strategies for therapeutic intervention . Mol Med Today. 2:1996;349-358.
24. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
25. Siebelist U., Franzoso G., Brown K. Structure, regulation and function of NF-kB. Annu Rev Cell Bio. 10:1994;405-455.
26. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol. 15:1995;4971-4979.
27. Szekanecz Z., Koch A., Kunkel S., Strieter R. Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs and Aging. 12:1998;377-390.
28. Takahashi N., Udagawa N., Akatsu T., Tanaka H., Isogai Y., Suda T. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology. 128:1991;1792-1796.
29. Tondravi M.M., McKercher S.R., Anderson K., et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 386:1997;81-84.
30. Wang Z.-Q., OVitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-Fos. Nature. 360:1992;741-745.
31. Wong B.R., Rho J., Arron J., et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190-25194.
32. Xing L.P., Carlson L., Siebenlist U., Boyce B.F. Mechanisms by which NF-kB regulates osteoclast numbers. Bone. 23:(Suppl.):1998;190.
33. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.
34. Yoshida H., Hayashi S., Kunisada T., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:1990;442-444.